Table 2 Demographic and clinical characteristics of the SARS-Cov-2 infected AR with SLIT or AR without SLIT groups.
Characteristics | Total | AR with SLIT | AR without SLIT | p-value |
|---|---|---|---|---|
Subjects, N (%) | 605 (100.0) | 122 (20.2) | 483 (79.8) | – |
Gender, male, N (%) | 357 (59.0) | 68 (55.7) | 289 (59.4) | 0.411 |
Age, year, mean (SD) | 22.3 (12.6) | 22 (10.4) | 22 (13.1) | 0.595 |
BMI, mean (SD) | 21.3 (3.7) | 21 (4.1) | 21 (3.6) | 0.623 |
Vaccination, N (%) | Â | Â | Â | 0.626 |
 Yes | 580 (0.5) | 116 (95.1) | 464 (96.1) |  |
 No | 25 (4.1) | 6 (4.918) | 19 (3.9) |  |
Smoking history, N (%) | Â | Â | Â | 0.852 |
 Yes | 18 (3.0) | 4 (3.3) | 14 (2.9) |  |
 No | 587 (97.0) | 118 (96.7) | 469 (97.1) |  |
Asthma, N (%) | Â | Â | Â | 0.090 |
 Yes | 31 (5.1) | 10 (8.2) | 21 (4.3) |  |
 No | 574 (94.9) | 112 (91.8) | 462 (95.7) |  |
SARS-CoV-2 infections during the study period, N (%) | Â | Â | Â | 0.569 |
 First | 602 (99.5) | 121 (99.2) | 481 (99.6) |  |
 Second | 3 (0.5) | 1 (0.8) | 2 (0.4) |  |
 Third | 0 (0.0) | 0 (0.0) | 0 (0.0) |  |
